Chinese Time Trade-Off Values for EQ-5D Health States

To generate a Chinese general population–based three-level EuroQol five-dimensios (EQ-5D-3L) social value set using the time trade-off method. The study sample was drawn from five cities in China: Beijing, Guangzhou, Shenyang, Chengdu, and Nanjing, using a quota sampling method. Utility values for a...

Full description

Saved in:
Bibliographic Details
Published inValue in health Vol. 17; no. 5; pp. 597 - 604
Main Authors Liu, Gordon G., Wu, Hongyan, Li, Minghui, Gao, Chen, Luo, Nan
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.07.2014
Elsevier
Subjects
Online AccessGet full text
ISSN1098-3015
1524-4733
1524-4733
DOI10.1016/j.jval.2014.05.007

Cover

Loading…
Abstract To generate a Chinese general population–based three-level EuroQol five-dimensios (EQ-5D-3L) social value set using the time trade-off method. The study sample was drawn from five cities in China: Beijing, Guangzhou, Shenyang, Chengdu, and Nanjing, using a quota sampling method. Utility values for a subset of 97 health states defined by the EQ-5D-3L descriptive system were directly elicited from the study sample using a modified Measurement and Valuation of Health protocol, with each respondent valuing 13 of the health states. The utility values for all 243 EQ-5D-3L health states were estimated on the basis of econometric models at both individual and aggregate levels. Various linear regression models using different model specifications were examined to determine the best model using predefined model selection criteria. The N3 model based on ordinary least square regression at the aggregate level yielded the best model fit, with a mean absolute error of 0.020, 7 and 0 states for which prediction errors were greater than 0.05 and 0.10, respectively, in absolute magnitude. This model passed tests for model misspecification (F = 2.7; P = 0.0509, Ramsey Regression Equation Specification Error Test), heteroskedasticity (χ2 = 0.97; P = 0.3254, Breusch-Pagan/Cook-Weisberg test), and normality of the residuals (χ2 = 1.285; P = 0.5259, Jarque-Bera test). The range of the predicted values (−0.149 to 0.887) was similar to those estimated in other countries. The study successfully developed Chinese utility values for EQ-5D-3L health states using the time trade-off method. It is the first attempt ever to develop a standardized instrument for quantifying quality-adjusted life-years in China.
AbstractList AbstractObjectiveTo generate a Chinese general population–based three-level EuroQol five-dimensios (EQ-5D-3L) social value set using the time trade-off method. MethodsThe study sample was drawn from five cities in China: Beijing, Guangzhou, Shenyang, Chengdu, and Nanjing, using a quota sampling method. Utility values for a subset of 97 health states defined by the EQ-5D-3L descriptive system were directly elicited from the study sample using a modified Measurement and Valuation of Health protocol, with each respondent valuing 13 of the health states. The utility values for all 243 EQ-5D-3L health states were estimated on the basis of econometric models at both individual and aggregate levels. Various linear regression models using different model specifications were examined to determine the best model using predefined model selection criteria. ResultsThe N3 model based on ordinary least square regression at the aggregate level yielded the best model fit, with a mean absolute error of 0.020, 7 and 0 states for which prediction errors were greater than 0.05 and 0.10, respectively, in absolute magnitude. This model passed tests for model misspecification (F = 2.7; P = 0.0509, Ramsey Regression Equation Specification Error Test), heteroskedasticity (χ 2 = 0.97; P = 0.3254, Breusch-Pagan/Cook-Weisberg test), and normality of the residuals (χ 2 = 1.285; P = 0.5259, Jarque-Bera test). The range of the predicted values (−0.149 to 0.887) was similar to those estimated in other countries. ConclusionsThe study successfully developed Chinese utility values for EQ-5D-3L health states using the time trade-off method. It is the first attempt ever to develop a standardized instrument for quantifying quality-adjusted life-years in China.
To generate a Chinese general population–based three-level EuroQol five-dimensios (EQ-5D-3L) social value set using the time trade-off method. The study sample was drawn from five cities in China: Beijing, Guangzhou, Shenyang, Chengdu, and Nanjing, using a quota sampling method. Utility values for a subset of 97 health states defined by the EQ-5D-3L descriptive system were directly elicited from the study sample using a modified Measurement and Valuation of Health protocol, with each respondent valuing 13 of the health states. The utility values for all 243 EQ-5D-3L health states were estimated on the basis of econometric models at both individual and aggregate levels. Various linear regression models using different model specifications were examined to determine the best model using predefined model selection criteria. The N3 model based on ordinary least square regression at the aggregate level yielded the best model fit, with a mean absolute error of 0.020, 7 and 0 states for which prediction errors were greater than 0.05 and 0.10, respectively, in absolute magnitude. This model passed tests for model misspecification (F = 2.7; P = 0.0509, Ramsey Regression Equation Specification Error Test), heteroskedasticity (χ2 = 0.97; P = 0.3254, Breusch-Pagan/Cook-Weisberg test), and normality of the residuals (χ2 = 1.285; P = 0.5259, Jarque-Bera test). The range of the predicted values (−0.149 to 0.887) was similar to those estimated in other countries. The study successfully developed Chinese utility values for EQ-5D-3L health states using the time trade-off method. It is the first attempt ever to develop a standardized instrument for quantifying quality-adjusted life-years in China.
To generate a Chinese general population-based three-level EuroQol five-dimensios (EQ-5D-3L) social value set using the time trade-off method.OBJECTIVETo generate a Chinese general population-based three-level EuroQol five-dimensios (EQ-5D-3L) social value set using the time trade-off method.The study sample was drawn from five cities in China: Beijing, Guangzhou, Shenyang, Chengdu, and Nanjing, using a quota sampling method. Utility values for a subset of 97 health states defined by the EQ-5D-3L descriptive system were directly elicited from the study sample using a modified Measurement and Valuation of Health protocol, with each respondent valuing 13 of the health states. The utility values for all 243 EQ-5D-3L health states were estimated on the basis of econometric models at both individual and aggregate levels. Various linear regression models using different model specifications were examined to determine the best model using predefined model selection criteria.METHODSThe study sample was drawn from five cities in China: Beijing, Guangzhou, Shenyang, Chengdu, and Nanjing, using a quota sampling method. Utility values for a subset of 97 health states defined by the EQ-5D-3L descriptive system were directly elicited from the study sample using a modified Measurement and Valuation of Health protocol, with each respondent valuing 13 of the health states. The utility values for all 243 EQ-5D-3L health states were estimated on the basis of econometric models at both individual and aggregate levels. Various linear regression models using different model specifications were examined to determine the best model using predefined model selection criteria.The N3 model based on ordinary least square regression at the aggregate level yielded the best model fit, with a mean absolute error of 0.020, 7 and 0 states for which prediction errors were greater than 0.05 and 0.10, respectively, in absolute magnitude. This model passed tests for model misspecification (F = 2.7; P = 0.0509, Ramsey Regression Equation Specification Error Test), heteroskedasticity (χ(2) = 0.97; P = 0.3254, Breusch-Pagan/Cook-Weisberg test), and normality of the residuals (χ(2) = 1.285; P = 0.5259, Jarque-Bera test). The range of the predicted values (-0.149 to 0.887) was similar to those estimated in other countries.RESULTSThe N3 model based on ordinary least square regression at the aggregate level yielded the best model fit, with a mean absolute error of 0.020, 7 and 0 states for which prediction errors were greater than 0.05 and 0.10, respectively, in absolute magnitude. This model passed tests for model misspecification (F = 2.7; P = 0.0509, Ramsey Regression Equation Specification Error Test), heteroskedasticity (χ(2) = 0.97; P = 0.3254, Breusch-Pagan/Cook-Weisberg test), and normality of the residuals (χ(2) = 1.285; P = 0.5259, Jarque-Bera test). The range of the predicted values (-0.149 to 0.887) was similar to those estimated in other countries.The study successfully developed Chinese utility values for EQ-5D-3L health states using the time trade-off method. It is the first attempt ever to develop a standardized instrument for quantifying quality-adjusted life-years in China.CONCLUSIONSThe study successfully developed Chinese utility values for EQ-5D-3L health states using the time trade-off method. It is the first attempt ever to develop a standardized instrument for quantifying quality-adjusted life-years in China.
To generate a Chinese general population-based three-level EuroQol five-dimensios (EQ-5D-3L) social value set using the time trade-off method. The study sample was drawn from five cities in China: Beijing, Guangzhou, Shenyang, Chengdu, and Nanjing, using a quota sampling method. Utility values for a subset of 97 health states defined by the EQ-5D-3L descriptive system were directly elicited from the study sample using a modified Measurement and Valuation of Health protocol, with each respondent valuing 13 of the health states. The utility values for all 243 EQ-5D-3L health states were estimated on the basis of econometric models at both individual and aggregate levels. Various linear regression models using different model specifications were examined to determine the best model using predefined model selection criteria. The N3 model based on ordinary least square regression at the aggregate level yielded the best model fit, with a mean absolute error of 0.020, 7 and 0 states for which prediction errors were greater than 0.05 and 0.10, respectively, in absolute magnitude. This model passed tests for model misspecification (F = 2.7; P = 0.0509, Ramsey Regression Equation Specification Error Test), heteroskedasticity (χ(2) = 0.97; P = 0.3254, Breusch-Pagan/Cook-Weisberg test), and normality of the residuals (χ(2) = 1.285; P = 0.5259, Jarque-Bera test). The range of the predicted values (-0.149 to 0.887) was similar to those estimated in other countries. The study successfully developed Chinese utility values for EQ-5D-3L health states using the time trade-off method. It is the first attempt ever to develop a standardized instrument for quantifying quality-adjusted life-years in China.
Author Luo, Nan
Liu, Gordon G.
Li, Minghui
Wu, Hongyan
Gao, Chen
Author_xml – sequence: 1
  givenname: Gordon G.
  surname: Liu
  fullname: Liu, Gordon G.
  organization: National School of Development, Peking University, Beijing, China
– sequence: 2
  givenname: Hongyan
  surname: Wu
  fullname: Wu, Hongyan
  organization: School of Medicine and Health Management, Guiyang Medical University, Guiyang, China
– sequence: 3
  givenname: Minghui
  surname: Li
  fullname: Li, Minghui
  organization: South Carolina College of Pharmacy, University of South Carolina, Columbia, SC
– sequence: 4
  givenname: Chen
  surname: Gao
  fullname: Gao, Chen
  organization: Novo Nordisk (China) Pharmaceuticals Co., Ltd., Beijing, China
– sequence: 5
  givenname: Nan
  surname: Luo
  fullname: Luo, Nan
  email: nan_luo@nuhs.edu.sg
  organization: Saw Swee Hock School of Public Health, National University of Singapore, Singapore
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28765635$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/25128053$$D View this record in MEDLINE/PubMed
BookMark eNqFkl9rFTEQxYNU7B_9Aj7Ivgi-7DpJdrJZEUGu1QqFIq2-htzsLM26N9smewv99ma5twgF60uSh985M3Myx-wgTIEYe82h4sDV-6Ea7uxYCeB1BVgBNM_YEUdRl3Uj5UF-Q6tLCRwP2XFKAwAoKfAFOxTIhQaURwxX1z5QouLKb_IRbUflRd8Xv-y4pVT0UyxOf5T4pTgjO87XxeVsZ0ov2fPejole7e8T9vPr6dXqrDy_-PZ99fm8dChwLlG1QqDU3bq3iARcNK3uFDU1t6oBp4Tgqmtyg33b9Ly1om5pjaQ0pzW1IE_Yu53vTZxucz-z2fjkaBxtoGmbDEeUDV9qZPTNHt2uN9SZm-g3Nt6bh1Ez8HYP2OTs2EcbnE9_Od0oVBIzp3eci1NKkXrjfB7aT2GO1o-Gg1nSN4NZ0jdL-gbQ5PSzVDySPrg_Kfq4E1EO8s5TNMl5Co46H8nNppv80_JPj-Ru9MHnCX_TPaVh2saQv8hwk4QBc7nsxLISvAautdDZ4MO_Df5X_Q8wwcFj
CitedBy_id crossref_primary_10_1080_02713683_2024_2355659
crossref_primary_10_1007_s00520_023_08240_1
crossref_primary_10_1080_03007995_2023_2178081
crossref_primary_10_1186_s12955_022_02076_9
crossref_primary_10_1007_s12020_019_02129_y
crossref_primary_10_1111_ecc_13283
crossref_primary_10_1111_os_12925
crossref_primary_10_1007_s11136_018_1928_y
crossref_primary_10_1007_s11136_021_02786_5
crossref_primary_10_1038_s41598_023_33248_2
crossref_primary_10_1371_journal_pone_0263912
crossref_primary_10_1186_s12939_023_02057_4
crossref_primary_10_1038_srep37838
crossref_primary_10_1016_j_phymed_2022_154391
crossref_primary_10_2147_NDT_S230403
crossref_primary_10_1186_s12939_020_1148_2
crossref_primary_10_1111_ggi_13895
crossref_primary_10_1186_s12955_022_01988_w
crossref_primary_10_1016_j_jval_2020_12_019
crossref_primary_10_1097_SLA_0000000000006149
crossref_primary_10_1371_journal_pone_0175847
crossref_primary_10_1186_s12889_020_10038_3
crossref_primary_10_2147_JMDH_S436486
crossref_primary_10_1056_NEJMoa2314741
crossref_primary_10_1038_s41598_022_13910_x
crossref_primary_10_1186_s13013_016_0083_x
crossref_primary_10_1371_journal_pone_0302592
crossref_primary_10_3389_fneur_2025_1551332
crossref_primary_10_3389_fpubh_2021_654822
crossref_primary_10_1186_s12955_019_1109_x
crossref_primary_10_1186_s12955_022_01917_x
crossref_primary_10_1080_14737167_2022_2091546
crossref_primary_10_1016_j_vhri_2017_03_006
crossref_primary_10_1007_s10198_020_01233_5
crossref_primary_10_1016_j_sleep_2022_12_001
crossref_primary_10_1007_s00586_017_5330_1
crossref_primary_10_1186_s12939_019_1099_7
crossref_primary_10_1177_00469580241264187
crossref_primary_10_1038_s41371_018_0092_8
crossref_primary_10_1016_j_breast_2018_03_004
crossref_primary_10_1097_MD_0000000000014719
crossref_primary_10_1007_s00520_020_05729_x
crossref_primary_10_1186_s12957_022_02619_w
crossref_primary_10_1007_s00592_020_01618_1
crossref_primary_10_1007_s40273_020_00997_1
crossref_primary_10_1007_s12072_021_10240_4
crossref_primary_10_1136_bmjopen_2023_079305
crossref_primary_10_1186_s12955_023_02180_4
crossref_primary_10_1016_j_bja_2023_06_029
crossref_primary_10_1111_inr_12333
crossref_primary_10_1186_s12955_024_02276_5
crossref_primary_10_1016_j_chest_2022_12_037
crossref_primary_10_1186_s12905_015_0190_5
crossref_primary_10_1186_s12955_020_01476_z
crossref_primary_10_1007_s11096_019_00870_y
crossref_primary_10_3389_fpubh_2022_961019
crossref_primary_10_1186_s12889_024_20999_4
crossref_primary_10_1186_s12916_022_02601_z
crossref_primary_10_1080_13696998_2023_2207742
crossref_primary_10_2196_18333
crossref_primary_10_3389_fonc_2022_1016258
crossref_primary_10_7189_jogh_11_08001
crossref_primary_10_1007_s40273_022_01151_9
crossref_primary_10_1186_s12889_021_11414_3
crossref_primary_10_1007_s11136_021_02853_x
crossref_primary_10_1111_iwj_13907
crossref_primary_10_2196_29906
crossref_primary_10_1097_BRS_0000000000002287
crossref_primary_10_1186_s12879_017_2801_2
crossref_primary_10_1007_s11136_020_02551_0
crossref_primary_10_3389_fpubh_2024_1334081
crossref_primary_10_1016_j_ijnurstu_2020_103703
crossref_primary_10_1007_s11136_023_03394_1
crossref_primary_10_1136_bmjopen_2017_015880
crossref_primary_10_1371_journal_pone_0184266
crossref_primary_10_1007_s11205_015_1221_1
crossref_primary_10_3389_fpubh_2020_507785
crossref_primary_10_1016_j_jval_2018_04_1370
crossref_primary_10_1136_bmjopen_2023_072854
crossref_primary_10_1213_ANE_0000000000005841
crossref_primary_10_1016_j_jval_2020_06_010
crossref_primary_10_1016_j_vhri_2021_04_007
crossref_primary_10_1186_s12889_022_13146_4
crossref_primary_10_1007_s11136_014_0902_6
crossref_primary_10_1007_s11136_020_02636_w
crossref_primary_10_3233_JAD_240583
crossref_primary_10_1002_hpm_2851
crossref_primary_10_2147_JIR_S282249
crossref_primary_10_1111_1753_0407_13294
crossref_primary_10_1111_papr_12931
crossref_primary_10_1007_s00198_019_05173_6
crossref_primary_10_1016_j_jenvman_2023_117619
crossref_primary_10_1007_s12603_016_0784_0
crossref_primary_10_1016_j_archger_2018_01_008
crossref_primary_10_1007_s10198_014_0635_z
crossref_primary_10_1007_s12603_019_1189_7
crossref_primary_10_1111_cns_12329
crossref_primary_10_1186_s12955_024_02315_1
crossref_primary_10_1371_journal_pone_0238980
crossref_primary_10_1007_s40258_022_00732_1
crossref_primary_10_1186_s12939_020_01348_4
crossref_primary_10_1186_s12889_019_7351_7
crossref_primary_10_1007_s12603_020_1327_2
crossref_primary_10_1080_13548506_2020_1856896
crossref_primary_10_1007_s10198_022_01465_7
crossref_primary_10_1177_0272989X18778295
crossref_primary_10_3390_ijerph20010475
crossref_primary_10_1186_s12889_023_15075_2
crossref_primary_10_62347_XKUJ3012
crossref_primary_10_1038_s41467_023_39483_5
crossref_primary_10_1097_BRS_0000000000003116
crossref_primary_10_3389_fpubh_2021_713480
crossref_primary_10_2340_jrm_v56_24102
crossref_primary_10_1007_s40520_023_02656_9
crossref_primary_10_1097_BRS_0000000000002939
crossref_primary_10_1371_journal_pone_0164334
crossref_primary_10_1001_jamanetworkopen_2023_55564
crossref_primary_10_1136_bmjopen_2018_024080
crossref_primary_10_1186_s40064_016_3613_3
crossref_primary_10_1177_2396987316683780
crossref_primary_10_2196_22288
crossref_primary_10_1016_j_gie_2021_08_008
crossref_primary_10_1016_j_jval_2016_11_016
crossref_primary_10_1016_S2468_1253_21_00313_7
crossref_primary_10_1111_os_13904
crossref_primary_10_1186_s12955_018_0905_z
crossref_primary_10_1161_STROKEAHA_119_027639
crossref_primary_10_1186_s12955_018_0865_3
crossref_primary_10_1007_s40273_016_0404_1
crossref_primary_10_1007_s40273_022_01172_4
crossref_primary_10_1186_s12877_024_05093_z
crossref_primary_10_1007_s11136_017_1614_5
crossref_primary_10_1097_MD_0000000000034718
crossref_primary_10_1186_s12955_018_1036_2
crossref_primary_10_1007_s44197_021_00028_y
crossref_primary_10_1016_j_jval_2015_10_010
crossref_primary_10_1111_sms_14771
crossref_primary_10_1177_0194599818800477
crossref_primary_10_1007_s11136_020_02749_2
crossref_primary_10_1007_s40273_018_0623_8
crossref_primary_10_2147_JPR_S289018
crossref_primary_10_1016_j_vhri_2023_07_004
crossref_primary_10_1186_s12889_024_20575_w
crossref_primary_10_1007_s11136_024_03776_z
crossref_primary_10_1007_s11136_020_02436_2
crossref_primary_10_1016_j_jdin_2020_03_003
crossref_primary_10_2217_cer_2016_0086
crossref_primary_10_1002_dmrr_3053
crossref_primary_10_1186_s12955_023_02183_1
crossref_primary_10_1111_os_12512
crossref_primary_10_1177_1054773820947984
crossref_primary_10_2147_CMAR_S250422
crossref_primary_10_1136_bmjopen_2018_021822
crossref_primary_10_1186_s12913_016_1536_x
crossref_primary_10_3389_fpubh_2023_1300404
crossref_primary_10_1016_j_ijnss_2022_09_015
crossref_primary_10_3389_fonc_2022_983704
crossref_primary_10_1016_j_vhri_2017_05_004
crossref_primary_10_1111_irv_13180
crossref_primary_10_1186_s12889_021_10847_0
crossref_primary_10_1186_s12889_025_22203_7
crossref_primary_10_1080_13696998_2018_1470977
crossref_primary_10_1155_2021_9972386
crossref_primary_10_1007_s11136_020_02645_9
crossref_primary_10_1016_j_jval_2023_03_003
crossref_primary_10_1038_s41598_023_35002_0
crossref_primary_10_3389_fmed_2024_1451979
crossref_primary_10_1002_sim_8592
crossref_primary_10_1016_j_puhe_2015_10_009
crossref_primary_10_1186_s12879_023_08940_3
crossref_primary_10_1371_journal_pone_0184883
crossref_primary_10_1007_s40258_025_00954_z
crossref_primary_10_1016_S2468_1253_21_00110_2
crossref_primary_10_1371_journal_pone_0234850
crossref_primary_10_1186_s12877_024_05646_2
crossref_primary_10_1097_MLR_0000000000001417
crossref_primary_10_1007_s00520_023_08231_2
crossref_primary_10_1038_s41598_017_15083_4
crossref_primary_10_3390_atmos12121551
crossref_primary_10_1111_dom_16325
crossref_primary_10_1111_1759_7714_13368
crossref_primary_10_1007_s11136_020_02524_3
crossref_primary_10_1007_s10067_023_06659_9
crossref_primary_10_1016_j_socscimed_2019_04_018
crossref_primary_10_3390_ijerph17041351
crossref_primary_10_1186_s13063_021_05392_5
crossref_primary_10_1177_0272989X15606903
crossref_primary_10_1007_s11136_019_02336_0
crossref_primary_10_1186_s12955_020_01324_0
crossref_primary_10_1097_CM9_0000000000002847
crossref_primary_10_1186_s12877_024_05249_x
crossref_primary_10_1186_s12955_020_01325_z
crossref_primary_10_1186_s12913_019_4206_y
crossref_primary_10_2147_JAA_S460300
crossref_primary_10_1097_MAO_0000000000003907
crossref_primary_10_1371_journal_pone_0229652
crossref_primary_10_2215_CJN_06800619
crossref_primary_10_1111_ggi_14893
crossref_primary_10_1111_jan_16397
crossref_primary_10_1016_j_jamda_2019_02_024
crossref_primary_10_1371_journal_pone_0204118
crossref_primary_10_3390_ijerph16081314
crossref_primary_10_1016_j_envint_2019_105041
crossref_primary_10_1111_jgh_15238
crossref_primary_10_3402_gha_v9_32261
crossref_primary_10_1186_s12955_015_0347_9
crossref_primary_10_1007_s12325_023_02576_0
crossref_primary_10_1186_s12877_017_0679_x
crossref_primary_10_1016_j_cjtee_2018_05_001
crossref_primary_10_1186_s12955_016_0499_2
crossref_primary_10_1016_j_jval_2020_11_012
crossref_primary_10_1136_jnnp_2016_314414
crossref_primary_10_1016_j_vhri_2020_07_580
crossref_primary_10_1007_s11136_018_2032_z
crossref_primary_10_1080_15402002_2022_2025805
crossref_primary_10_1007_s40271_017_0220_5
crossref_primary_10_1186_s12955_024_02275_6
crossref_primary_10_2217_cer_2017_0069
crossref_primary_10_1186_s12874_020_01008_9
crossref_primary_10_1002_cam4_1817
crossref_primary_10_1016_j_jval_2018_05_008
crossref_primary_10_3390_ijerph17249261
crossref_primary_10_1016_j_lungcan_2021_12_009
crossref_primary_10_3390_ijerph14030224
crossref_primary_10_1007_s11136_023_03512_z
crossref_primary_10_1002_pon_5160
crossref_primary_10_1007_s40273_022_01216_9
crossref_primary_10_1186_s12955_020_01409_w
crossref_primary_10_1186_s12955_020_01632_5
crossref_primary_10_3389_fpubh_2020_580757
crossref_primary_10_1136_bmjopen_2023_081140
crossref_primary_10_1007_s11136_021_02883_5
crossref_primary_10_1007_s10389_023_02077_y
crossref_primary_10_3389_fpubh_2022_955615
crossref_primary_10_1186_s12885_018_4855_y
crossref_primary_10_1200_GO_24_00044
crossref_primary_10_3390_ijerph16081336
crossref_primary_10_3389_fphar_2022_916421
crossref_primary_10_1007_s40271_020_00466_z
crossref_primary_10_1186_s12955_019_1175_0
crossref_primary_10_1007_s11136_020_02644_w
crossref_primary_10_1007_s10198_024_01682_2
crossref_primary_10_1177_15347354211002919
crossref_primary_10_1016_j_jvacx_2023_100415
crossref_primary_10_1186_s12955_024_02309_z
crossref_primary_10_1038_srep17301
crossref_primary_10_1186_s12886_023_03106_w
crossref_primary_10_1136_bmjdrc_2024_004120
crossref_primary_10_1007_s11136_019_02292_9
crossref_primary_10_1007_s13555_023_01041_8
crossref_primary_10_1111_1753_0407_13473
crossref_primary_10_3389_ijph_2021_1604025
Cites_doi 10.1016/S0167-6296(01)00130-8
10.1097/00005650-200202000-00006
10.1111/j.1524-4733.2009.00579.x
10.2165/00019053-199507060-00004
10.1002/hec.1124
10.1007/s11136-011-9903-x
10.1111/j.1524-4733.2008.00413.x
10.1097/01.mlr.0000252166.76255.68
10.1097/00005650-200503000-00003
10.1111/j.1524-4733.2008.00468.x
10.1016/S0929-6646(08)60078-9
10.1007/s11136-010-9678-5
10.1016/0168-8510(96)00822-6
10.47102/annals-acadmedsg.V32N5p685
10.1177/0272989X06286480
10.1097/00005650-199711000-00002
10.1002/hec.673
10.1186/1478-7954-1-11
10.1007/s11136-004-0612-6
10.1111/j.1524-4733.2008.00348.x
10.2165/11314120-000000000-00000
10.1016/j.jval.2010.11.016
ContentType Journal Article
Copyright 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
2015 INIST-CNRS
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
– notice: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
– notice: 2015 INIST-CNRS
– notice: Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.
DBID 6I.
AAFTH
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.jval.2014.05.007
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList


MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
Public Health
EISSN 1524-4733
EndPage 604
ExternalDocumentID 25128053
28765635
10_1016_j_jval_2014_05_007
S1098301514018828
1_s2_0_S1098301514018828
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Asia
China
GeographicLocations_xml – name: China
GroupedDBID ---
--K
--M
.1-
.3N
.FO
.GA
.Y3
.~1
0R~
10A
123
1OC
1P~
1~.
29Q
31~
36B
4.4
44B
457
4G.
51W
51X
52N
52P
52R
52S
52X
53G
5LA
5VS
66C
6PF
7-5
7PT
8-1
8P~
8UM
AAEDT
AAEDW
AAFJI
AAFWJ
AAIKJ
AAKOC
AALRI
AAMMB
AAOAW
AAPFB
AAQFI
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABCQN
ABDBF
ABEML
ABIVO
ABJNI
ABMAC
ABMMH
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFS
ACHQT
ACIEU
ACPRK
ACRLP
ACRPL
ACUHS
ACVFH
ACXQS
ADBBV
ADCNI
ADEZE
ADFHU
ADMUD
ADNMO
ADVLN
AEBSH
AEFGJ
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AEXQZ
AEYQN
AFBPY
AFEBI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AFZJQ
AGCQF
AGHFR
AGQPQ
AGTHC
AGUBO
AGXDD
AGYEJ
AIDQK
AIDYY
AIEXJ
AIGII
AIIAU
AIIUN
AIKHN
AITUG
AJAOE
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
AOMHK
APXCP
ASPBG
AVARZ
AVWKF
AXJTR
AXLSJ
AZFZN
BAWUL
BFHJK
BKOJK
BLXMC
BNPGV
BY8
CAG
CO8
COF
CS3
DCZOG
DIK
DU5
EAD
EAP
EBS
EFJIC
EFKBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
GBLVA
HF~
HVGLF
HZI
HZ~
IHE
IXB
KOM
LH4
M41
MO0
N9A
O-L
O9-
OAUVE
OIG
OK1
OVD
P-8
P-9
P2P
PC.
PQQKQ
PRBVW
Q38
QB0
R2-
ROL
SDF
SEL
SES
SPCBC
SSB
SSF
SSH
SSO
SSZ
SV3
T5K
TEORI
TUS
W99
WIN
WYUIH
XG1
YFH
Z5R
~G-
0SF
6I.
AACTN
AAFTH
AAHHS
ABVKL
ACCFJ
AEEZP
AEQDE
AFCTW
AFKWA
AIWBW
AJBDE
AJOXV
AMFUW
NCXOZ
RIG
SUPJJ
AAIAV
ABLVK
ABYKQ
AJBFU
AKYCK
EFLBG
IXIXF
LCYCR
AAYXX
AGRNS
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c525t-56922538dbfa55e012798d6e741a670c62216d7015f97f19a249eb5e681ebe903
IEDL.DBID IXB
ISSN 1098-3015
1524-4733
IngestDate Fri Jul 11 16:53:00 EDT 2025
Mon Jul 21 05:24:33 EDT 2025
Wed Apr 02 07:24:01 EDT 2025
Thu Apr 24 23:02:53 EDT 2025
Tue Jul 01 03:45:22 EDT 2025
Fri Feb 23 02:33:42 EST 2024
Mon Feb 24 20:26:29 EST 2025
Tue Aug 26 18:38:38 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords EQ-5D
utility
social value set
China
TTO
Asiatic
Value
Chinese
Time trade-off
Social aspect
Public health
Language English
License http://creativecommons.org/licenses/by-nc-nd/3.0
CC BY 4.0
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c525t-56922538dbfa55e012798d6e741a670c62216d7015f97f19a249eb5e681ebe903
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S1098301514018828
PMID 25128053
PQID 1553712253
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_1553712253
pubmed_primary_25128053
pascalfrancis_primary_28765635
crossref_citationtrail_10_1016_j_jval_2014_05_007
crossref_primary_10_1016_j_jval_2014_05_007
elsevier_sciencedirect_doi_10_1016_j_jval_2014_05_007
elsevier_clinicalkeyesjournals_1_s2_0_S1098301514018828
elsevier_clinicalkey_doi_10_1016_j_jval_2014_05_007
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-07-01
PublicationDateYYYYMMDD 2014-07-01
PublicationDate_xml – month: 07
  year: 2014
  text: 2014-07-01
  day: 01
PublicationDecade 2010
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
PublicationTitle Value in health
PublicationTitleAlternate Value Health
PublicationYear 2014
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Shaw, Johnson, Coons (bib21) 2005; 43
Ma (bib13) 2010
Lamers, Stalmeier, Krabbe (bib28) 2006; 26
Dolan (bib20) 1997; 35
Feeny, Furlong, Torrance (bib3) 2002; 40
Brooks (bib4) 1996; 37
Lee, Nam, Chuang (bib15) 2009; 12
Lamers, McDonnell, Stalmeier (bib1) 2006; 15
Augustovski, Irazola, Velazquez (bib26) 2009; 12
Feeny, Furlong, Boyle, Torrance (bib2) 1995; 7
Bailey, Kind (bib7) 2010; 19
Luo, Chew, Fong (bib11) 2003; 32
Jelsma, Hansen, De Weerdt (bib25) 2003; 1
Knies, Evers, Candel (bib8) 2009; 27
Yang, Brazier, Tsuchiya, Coyne (bib23) 2009; 12
Herdman, Gudex, Lloyd (bib5) 2011; 20
Jo, Yun, Lee (bib19) 2008; 11
China guidelines for pharmacoeconomic evaluations (2011). 2011. Available from
Chang, Tarn, Hsieh (bib12) 2007; 106
Szende, Oppe, Devlin (bib17) 2007
Dolan, Roberts (bib22) 2002; 40
[Accessed April 9, 2011].
Tsuchiya, Ikeda, Ikegami (bib14) 2002; 11
View on deepening the health care system reform by CPC Central Committee and the State Council. 2009. Available from
Lamers (bib18) 2007; 45
[Accessed March 17, 2009].
Montejo, Correas-Lauffer, Maurino (bib27) 2011; 14
Brazier, Roberts, Deverill (bib6) 2002; 21
Kind (bib16) 2009
Wang, Kindig, Mullahy (bib10) 2005; 14
Feeny (10.1016/j.jval.2014.05.007_bib3) 2002; 40
Chang (10.1016/j.jval.2014.05.007_bib12) 2007; 106
10.1016/j.jval.2014.05.007_bib24
Feeny (10.1016/j.jval.2014.05.007_bib2) 1995; 7
Brooks (10.1016/j.jval.2014.05.007_bib4) 1996; 37
10.1016/j.jval.2014.05.007_bib9
Knies (10.1016/j.jval.2014.05.007_bib8) 2009; 27
Augustovski (10.1016/j.jval.2014.05.007_bib26) 2009; 12
Brazier (10.1016/j.jval.2014.05.007_bib6) 2002; 21
Luo (10.1016/j.jval.2014.05.007_bib11) 2003; 32
Kind (10.1016/j.jval.2014.05.007_bib16) 2009
Lamers (10.1016/j.jval.2014.05.007_bib1) 2006; 15
Lamers (10.1016/j.jval.2014.05.007_bib18) 2007; 45
Tsuchiya (10.1016/j.jval.2014.05.007_bib14) 2002; 11
Bailey (10.1016/j.jval.2014.05.007_bib7) 2010; 19
Lee (10.1016/j.jval.2014.05.007_bib15) 2009; 12
Szende (10.1016/j.jval.2014.05.007_bib17) 2007
Lamers (10.1016/j.jval.2014.05.007_bib28) 2006; 26
Wang (10.1016/j.jval.2014.05.007_bib10) 2005; 14
Montejo (10.1016/j.jval.2014.05.007_bib27) 2011; 14
Jelsma (10.1016/j.jval.2014.05.007_bib25) 2003; 1
Shaw (10.1016/j.jval.2014.05.007_bib21) 2005; 43
Ma (10.1016/j.jval.2014.05.007_bib13) 2010
Dolan (10.1016/j.jval.2014.05.007_bib22) 2002; 40
Dolan (10.1016/j.jval.2014.05.007_bib20) 1997; 35
Yang (10.1016/j.jval.2014.05.007_bib23) 2009; 12
Jo (10.1016/j.jval.2014.05.007_bib19) 2008; 11
Herdman (10.1016/j.jval.2014.05.007_bib5) 2011; 20
References_xml – volume: 40
  start-page: 113
  year: 2002
  end-page: 128
  ident: bib3
  article-title: Multiattribute and single-attribute utility functions for the health utilities index mark 3 system
  publication-title: Med Care
– volume: 14
  start-page: 119
  year: 2005
  end-page: 132
  ident: bib10
  article-title: Variation in Chinese population health related quality of life: results from a EuroQol study in Beijing, China
  publication-title: Qual Life Res
– volume: 11
  start-page: 341
  year: 2002
  end-page: 353
  ident: bib14
  article-title: Estimating an EQ-5D population value set: the case of Japan
  publication-title: Health Econ
– volume: 12
  start-page: 159
  year: 2009
  end-page: 166
  ident: bib23
  article-title: Estimating a preference-based single index from the Overactive Bladder Questionnaire
  publication-title: Value Health
– volume: 14
  start-page: 564
  year: 2011
  end-page: 570
  ident: bib27
  article-title: Estimation of a multiattribute utility function for the Spanish version of the TooL questionnaire
  publication-title: Value Health
– volume: 21
  start-page: 271
  year: 2002
  end-page: 292
  ident: bib6
  article-title: The estimation of a preference-based measure of health from the SF-36
  publication-title: J Health Econ
– volume: 40
  start-page: 442
  year: 2002
  end-page: 446
  ident: bib22
  article-title: Modeling valuations for EQ-5D health states: an alternative model using differences in valuations
  publication-title: Value Health
– year: 2010
  ident: bib13
  article-title: China Statistical Yearbook 2010
– reference: China guidelines for pharmacoeconomic evaluations (2011). 2011. Available from:
– volume: 27
  start-page: 767
  year: 2009
  end-page: 779
  ident: bib8
  article-title: Utilities of the EQ-5D: transferable or not?
  publication-title: Pharmacoeconomics
– reference: . [Accessed April 9, 2011].
– volume: 45
  start-page: 238
  year: 2007
  end-page: 244
  ident: bib18
  article-title: The transformation of utilities for health states worse than death: consequences for the estimation of EQ-5D value sets
  publication-title: Med Care
– volume: 11
  start-page: 1186
  year: 2008
  end-page: 1189
  ident: bib19
  article-title: Estimating quality weights for EQ-5D health states with the time trade-off method in South Korea
  publication-title: Value Health
– volume: 1
  start-page: 1
  year: 2003
  end-page: 10
  ident: bib25
  article-title: How do Zimbabweans value health states?
  publication-title: Popul Health Metr
– volume: 37
  start-page: 53
  year: 1996
  end-page: 72
  ident: bib4
  article-title: EuroQol: the current state of play
  publication-title: Health Policy
– volume: 12
  start-page: 587
  year: 2009
  end-page: 596
  ident: bib26
  article-title: Argentine valuation of the EQ-5D health states
  publication-title: Value Health
– volume: 26
  start-page: 173
  year: 2006
  end-page: 181
  ident: bib28
  article-title: Inconsistencies in TTO and VAS values for EQ-5D health states
  publication-title: Med Decis Making
– volume: 35
  start-page: 1095
  year: 1997
  end-page: 1108
  ident: bib20
  article-title: Modeling valuations for EuroQol health states
  publication-title: Med Care
– volume: 15
  start-page: 121
  year: 2006
  end-page: 132
  ident: bib1
  article-title: The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies
  publication-title: Health Econ
– year: 2007
  ident: bib17
  article-title: EQ-5D Value Sets: Inventory, Comparative Review and User Guide
– volume: 32
  start-page: 685
  year: 2003
  end-page: 690
  ident: bib11
  article-title: Validity and reliability of the EQ-5D self-report questionnaire in Chinese-speaking patients with rheumatic diseases in Singapore
  publication-title: Ann Acad Med Singapore
– year: 2009
  ident: bib16
  article-title: A Revised Protocol for the Valuation of Health States Defined by the EQ-5D-3L Classification System: Learning the Lessons from the MVH Study
  publication-title: York: Centre for Health Economics, University of York
– volume: 43
  start-page: 203
  year: 2005
  end-page: 220
  ident: bib21
  article-title: US valuation of the EQ-5D health states: development and testing of the D1 valuation model
  publication-title: Med Care
– volume: 7
  start-page: 490
  year: 1995
  end-page: 502
  ident: bib2
  article-title: Multi-attribute health status classification systems: health utilities index
  publication-title: Pharmacoeconomics
– volume: 12
  start-page: 1187
  year: 2009
  end-page: 1193
  ident: bib15
  article-title: South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states
  publication-title: Value Health
– reference: View on deepening the health care system reform by CPC Central Committee and the State Council. 2009. Available from:
– volume: 20
  start-page: 1727
  year: 2011
  end-page: 1736
  ident: bib5
  article-title: Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
  publication-title: Qual Life Res
– volume: 19
  start-page: 1145
  year: 2010
  end-page: 1154
  ident: bib7
  article-title: Preliminary findings of an investigation into the relationship between national culture and EQ-5D value sets
  publication-title: Qual Life Res
– reference: . [Accessed March 17, 2009].
– volume: 106
  start-page: 1023
  year: 2007
  end-page: 1031
  ident: bib12
  article-title: Taiwanese version of the EQ-5D: validation in a representative sample of the Taiwanese population
  publication-title: J Formos Med Assoc
– year: 2009
  ident: 10.1016/j.jval.2014.05.007_bib16
  article-title: A Revised Protocol for the Valuation of Health States Defined by the EQ-5D-3L Classification System: Learning the Lessons from the MVH Study
  publication-title: York: Centre for Health Economics, University of York
– ident: 10.1016/j.jval.2014.05.007_bib24
– volume: 21
  start-page: 271
  year: 2002
  ident: 10.1016/j.jval.2014.05.007_bib6
  article-title: The estimation of a preference-based measure of health from the SF-36
  publication-title: J Health Econ
  doi: 10.1016/S0167-6296(01)00130-8
– volume: 40
  start-page: 113
  year: 2002
  ident: 10.1016/j.jval.2014.05.007_bib3
  article-title: Multiattribute and single-attribute utility functions for the health utilities index mark 3 system
  publication-title: Med Care
  doi: 10.1097/00005650-200202000-00006
– volume: 12
  start-page: 1187
  year: 2009
  ident: 10.1016/j.jval.2014.05.007_bib15
  article-title: South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states
  publication-title: Value Health
  doi: 10.1111/j.1524-4733.2009.00579.x
– volume: 7
  start-page: 490
  year: 1995
  ident: 10.1016/j.jval.2014.05.007_bib2
  article-title: Multi-attribute health status classification systems: health utilities index
  publication-title: Pharmacoeconomics
  doi: 10.2165/00019053-199507060-00004
– year: 2007
  ident: 10.1016/j.jval.2014.05.007_bib17
– volume: 15
  start-page: 121
  year: 2006
  ident: 10.1016/j.jval.2014.05.007_bib1
  article-title: The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies
  publication-title: Health Econ
  doi: 10.1002/hec.1124
– volume: 20
  start-page: 1727
  year: 2011
  ident: 10.1016/j.jval.2014.05.007_bib5
  article-title: Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
  publication-title: Qual Life Res
  doi: 10.1007/s11136-011-9903-x
– volume: 12
  start-page: 159
  year: 2009
  ident: 10.1016/j.jval.2014.05.007_bib23
  article-title: Estimating a preference-based single index from the Overactive Bladder Questionnaire
  publication-title: Value Health
  doi: 10.1111/j.1524-4733.2008.00413.x
– volume: 45
  start-page: 238
  year: 2007
  ident: 10.1016/j.jval.2014.05.007_bib18
  article-title: The transformation of utilities for health states worse than death: consequences for the estimation of EQ-5D value sets
  publication-title: Med Care
  doi: 10.1097/01.mlr.0000252166.76255.68
– volume: 43
  start-page: 203
  year: 2005
  ident: 10.1016/j.jval.2014.05.007_bib21
  article-title: US valuation of the EQ-5D health states: development and testing of the D1 valuation model
  publication-title: Med Care
  doi: 10.1097/00005650-200503000-00003
– volume: 12
  start-page: 587
  year: 2009
  ident: 10.1016/j.jval.2014.05.007_bib26
  article-title: Argentine valuation of the EQ-5D health states
  publication-title: Value Health
  doi: 10.1111/j.1524-4733.2008.00468.x
– volume: 106
  start-page: 1023
  year: 2007
  ident: 10.1016/j.jval.2014.05.007_bib12
  article-title: Taiwanese version of the EQ-5D: validation in a representative sample of the Taiwanese population
  publication-title: J Formos Med Assoc
  doi: 10.1016/S0929-6646(08)60078-9
– year: 2010
  ident: 10.1016/j.jval.2014.05.007_bib13
– volume: 40
  start-page: 442
  year: 2002
  ident: 10.1016/j.jval.2014.05.007_bib22
  article-title: Modeling valuations for EQ-5D health states: an alternative model using differences in valuations
  publication-title: Value Health
– volume: 19
  start-page: 1145
  year: 2010
  ident: 10.1016/j.jval.2014.05.007_bib7
  article-title: Preliminary findings of an investigation into the relationship between national culture and EQ-5D value sets
  publication-title: Qual Life Res
  doi: 10.1007/s11136-010-9678-5
– volume: 37
  start-page: 53
  year: 1996
  ident: 10.1016/j.jval.2014.05.007_bib4
  article-title: EuroQol: the current state of play
  publication-title: Health Policy
  doi: 10.1016/0168-8510(96)00822-6
– volume: 32
  start-page: 685
  year: 2003
  ident: 10.1016/j.jval.2014.05.007_bib11
  article-title: Validity and reliability of the EQ-5D self-report questionnaire in Chinese-speaking patients with rheumatic diseases in Singapore
  publication-title: Ann Acad Med Singapore
  doi: 10.47102/annals-acadmedsg.V32N5p685
– volume: 26
  start-page: 173
  year: 2006
  ident: 10.1016/j.jval.2014.05.007_bib28
  article-title: Inconsistencies in TTO and VAS values for EQ-5D health states
  publication-title: Med Decis Making
  doi: 10.1177/0272989X06286480
– volume: 35
  start-page: 1095
  year: 1997
  ident: 10.1016/j.jval.2014.05.007_bib20
  article-title: Modeling valuations for EuroQol health states
  publication-title: Med Care
  doi: 10.1097/00005650-199711000-00002
– ident: 10.1016/j.jval.2014.05.007_bib9
– volume: 11
  start-page: 341
  year: 2002
  ident: 10.1016/j.jval.2014.05.007_bib14
  article-title: Estimating an EQ-5D population value set: the case of Japan
  publication-title: Health Econ
  doi: 10.1002/hec.673
– volume: 1
  start-page: 1
  year: 2003
  ident: 10.1016/j.jval.2014.05.007_bib25
  article-title: How do Zimbabweans value health states?
  publication-title: Popul Health Metr
  doi: 10.1186/1478-7954-1-11
– volume: 14
  start-page: 119
  year: 2005
  ident: 10.1016/j.jval.2014.05.007_bib10
  article-title: Variation in Chinese population health related quality of life: results from a EuroQol study in Beijing, China
  publication-title: Qual Life Res
  doi: 10.1007/s11136-004-0612-6
– volume: 11
  start-page: 1186
  year: 2008
  ident: 10.1016/j.jval.2014.05.007_bib19
  article-title: Estimating quality weights for EQ-5D health states with the time trade-off method in South Korea
  publication-title: Value Health
  doi: 10.1111/j.1524-4733.2008.00348.x
– volume: 27
  start-page: 767
  year: 2009
  ident: 10.1016/j.jval.2014.05.007_bib8
  article-title: Utilities of the EQ-5D: transferable or not?
  publication-title: Pharmacoeconomics
  doi: 10.2165/11314120-000000000-00000
– volume: 14
  start-page: 564
  year: 2011
  ident: 10.1016/j.jval.2014.05.007_bib27
  article-title: Estimation of a multiattribute utility function for the Spanish version of the TooL questionnaire
  publication-title: Value Health
  doi: 10.1016/j.jval.2010.11.016
SSID ssj0006325
Score 2.5392265
Snippet To generate a Chinese general population–based three-level EuroQol five-dimensios (EQ-5D-3L) social value set using the time trade-off method. The study sample...
AbstractObjectiveTo generate a Chinese general population–based three-level EuroQol five-dimensios (EQ-5D-3L) social value set using the time trade-off method....
To generate a Chinese general population-based three-level EuroQol five-dimensios (EQ-5D-3L) social value set using the time trade-off method. The study sample...
To generate a Chinese general population-based three-level EuroQol five-dimensios (EQ-5D-3L) social value set using the time trade-off method.OBJECTIVETo...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 597
SubjectTerms Adolescent
Adult
Biological and medical sciences
China
Data Collection
EQ-5D
Female
General aspects
Health Status
Humans
Internal Medicine
Least-Squares Analysis
Linear Models
Male
Medical sciences
Middle Aged
Miscellaneous
Models, Econometric
Models, Statistical
Planification. Prevention (methods). Intervention. Evaluation
Public Health
Public health. Hygiene
Public health. Hygiene-occupational medicine
Quality of Life
Quality-Adjusted Life Years
social value set
Surveys and Questionnaires
Time Factors
TTO
utility
Young Adult
Title Chinese Time Trade-Off Values for EQ-5D Health States
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1098301514018828
https://www.clinicalkey.es/playcontent/1-s2.0-S1098301514018828
https://dx.doi.org/10.1016/j.jval.2014.05.007
https://www.ncbi.nlm.nih.gov/pubmed/25128053
https://www.proquest.com/docview/1553712253
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9RAFH_UCiJI0ao1apcRpBc7biaTSTLHtrasSmvFVvY2ZDMz0FK2i9keeunf7nuZyS7FWsFjwjwyeZ-_Yd4HwHuPUVlnjeROi4rneZnx2sqU68w6La2tfddI-_CoGJ3mX8ZqvAJ7fS0MpVVG3x98euet45th5OZwdnY2_CFSXaF6KjoiIE6kgl-ZV10R33h34Y0L2Q1epcWcVsfCmZDjdY7SpPSuvOveSSNl7w5OT2Z1iyzzYdbF38FoF5QOnsJaRJNsJ2z4Gay46To8Ooz35euwdRw6U19vs5NloVW7zbbY8bJn9fVzUDRH27WOUUkIwwBmHf_mPftZX-AGGCJbtv-dq08slC2xgFFfwOnB_sneiMeJCrxRmZpzVWi0X1nZia-VcnTtrCtbOIQVdVGmTZFlorAlssnr0gtd4-HMTZQrKoHC1ql8CavTy6l7BUyqSS7xdIgx3ua5R7tHggaFK0pJTesTED0rTRPbjdPUiwvT55WdG2K_IfabVBlkfwIfFjSz0Gzj3tWyl5Dpy0jR8RmMBfdSlXdRuTbabmuEaTOTmj_0KwG1oLylov_84uCW-ix-DQ-riKalSuBdr08GjZtubOqpu7zCrSglS0EiS2AjKNqSGqFahS709X9u6w08pqeQevwWVue_rtwmAqz5ZAAPPt6IATzc-fx1dDTo7Ok3IWsfzA
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD4aQxpICMFgEGDDk9BemNU4jp34EXZRd-kYokN9s9LYljZNXUW6h_17jmOn1cTYpL0mPopzrp_lcwH44jAqq6zm1CpW0jwvMloZnlKVGau4MZVrG2kPTmT_LD8cidES7HS1MD6tMvr-4NNbbx2f9CI3e9Pz894vlqoS1VP4IwLixPIJPEU0IL1qH4y-z92x5O3kVb-a-uWxciYkeV2gOH1-V9627_QzZe-OTi-mVYM8c2HYxf_RaBuV9l_Bywgnybew49ewZCersDKIF-arsHUaWlPfbJPhotKq2SZb5HTRtPrmDQg_SNs2lviaEIIRzFj6wznyu7rEDRCEtmTvJxW7JNQtkQBS38LZ_t5wp0_jSAVai0zMqJAKDZiXZuwqIay_d1alkRZxRSWLtJZZxqQpkE1OFY6pCk9ndiysLBlKW6V8DZYnVxP7HggX45zj8RCDvMlzh4aPBDVKlxXcd61PgHWs1HXsN-7HXlzqLrHsQnv2a89-nQqN7E_g65xmGrpt3LuadxLSXR0pej6NweBequIuKttE4200002mU_2PgiUg5pS3dPTBL27cUp_5r-FpFeE0Fwlsdvqk0br9lU01sVfXuBUheMG8yBJ4FxRtQY1YrUQf-uGR2_oMz_rDwbE-Pjg5-gjP_ZuQh_wJlmd_ru06oq3ZeKO1pr_l8SBn
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chinese+Time+Trade-Off+Values+for+EQ-5D+Health+States&rft.jtitle=Value+in+health&rft.au=Liu%2C+Gordon+G.&rft.au=Wu%2C+Hongyan&rft.au=Li%2C+Minghui&rft.au=Gao%2C+Chen&rft.date=2014-07-01&rft.issn=1098-3015&rft.volume=17&rft.issue=5&rft.spage=597&rft.epage=604&rft_id=info:doi/10.1016%2Fj.jval.2014.05.007&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jval_2014_05_007
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F10983015%2FS1098301514X00057%2Fcov150h.gif